CellPrime™ recombinant human lysozyme can aid in increasing recovery efficiencies in biopharmaceutical production. Especially suited for lysing Micrococcus and E. coli, it can deliver a five-fold increase in target protein recovery. Since CellPrime recombinant human lysozyme is of nonanimal origin, it also decreases the risk of infectious disease transmission. CellPrime recombinant human lysozyme is available in large batch and pack sizes, and is suitable for use in large-scale processes.